Nitrilotriacetic acid trisodium salt
This substance was identified for action under the Chemicals Management Plan (CMP).
|CAS RN||Common name||DSL name||Public comments on the draft screening assessment||Final screening assessment||Conclusion on section 64 criteria||Follow-up activities|
|5064-31-3||Nitrilotriacetic acid trisodium salt (Na3NTA)||Glycine, N,N-bis(carboxymethyl)-, trisodium salt||HTML||HTML||Does not meet||Significant New Activity (SNAc) provisions|
Although Na3NTA is not considered to be harmful to human health at current levels of exposure, this substance is considered to have a health effect of concern based on its potential ability to cause cancer of the urinary tract based on laboratory studies. Therefore, there may be a potential risk if exposure to this substance were to increase. The proposed follow-up activity is to apply the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA 1999) to Na3NTA.
|November 26, 2022||Publication in the Canada Gazette, Part I: Vol. 156, No. 48, of a notice of intent to amend the Domestic Substances List to apply the SNAc provisions of CEPA 1999 and start of a 60-day public comment period.|
|November 26, 2022||Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 156, No. 48.|
|December 19, 2020||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 154, No. 51.|
- Date modified: